Related Experiment Video
Updated: Jul 2, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
[Interval cancers as indicators of performance in screening programmes]
Stefano Ciatto1, Carlo Naldoni, Antonio Ponti
1stefano.ciatto@gmail.com
Abstract:
GISMa analyses the interval cancer (IS) topic providing guidelines and reference standards in addition to CE recommendations. IC identification is based on Cancer Registries (CR), if existing, or on hospital discharge records, in alternative. The optimal measure of IC frequency (inversely correlated with sensitivity) is the IC proportional incidence (observed IC/carcinomas expected in absence of screening). Other formulas (IC/IC + screen detected cancers; IC rate per 1000 negative screens) look less reliable. IC stage at diagnosis (if available through CR) must be compared with screen detected cancer and cancer detected in non-attenders. Review of mammograms preceding the IC (coded as screening error, minimal signs, or occult) should be done mainly with a blind procedure (IC mixed with negative controls), as this procedure is more representative of the original scenario and more respectful of radiologist's rights.
Related Concept Videos
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Preventive Healthcare Services
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Bias in Epidemiological Studies
Cancer Survival Analysis
Kaplan-Meier Approach
